USA Transthyretin Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Transthyretin market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Transthyretin market. Detailed analysis of key players, along with key growth strategies adopted by Transthyretin industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Neurimmune Holding AG

    • Prothena Corp Plc

    • Pfizer Inc

    • Ionis Pharmaceuticals Inc

    • Regeneron Pharmaceuticals Inc

    • Arcturus Therapeutics Inc

    • Alnylam Pharmaceuticals Inc

    By Type:

    • AG-10

    • ALN-TTRsc02

    • CRX-1008

    • EDE-1307

    • Others

    By End-User:

    • Familial Amyloid Neuropathies

    • Alzheimer's Disease

    • Cardomyopathy

    • Neuropathy

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Transthyretin Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Transthyretin Market Size and Growth Rate of AG-10 from 2016 to 2027

      • 1.3.2 USA Transthyretin Market Size and Growth Rate of ALN-TTRsc02 from 2016 to 2027

      • 1.3.3 USA Transthyretin Market Size and Growth Rate of CRX-1008 from 2016 to 2027

      • 1.3.4 USA Transthyretin Market Size and Growth Rate of EDE-1307 from 2016 to 2027

      • 1.3.5 USA Transthyretin Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Transthyretin Market Size and Growth Rate of Familial Amyloid Neuropathies from 2016 to 2027

      • 1.4.2 USA Transthyretin Market Size and Growth Rate of Alzheimer's Disease from 2016 to 2027

      • 1.4.3 USA Transthyretin Market Size and Growth Rate of Cardomyopathy from 2016 to 2027

      • 1.4.4 USA Transthyretin Market Size and Growth Rate of Neuropathy from 2016 to 2027

      • 1.4.5 USA Transthyretin Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Transthyretin Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Transthyretin Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Transthyretin Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Transthyretin Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Transthyretin Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Transthyretin by Major Types

      • 3.4.1 Market Size and Growth Rate of AG-10

      • 3.4.2 Market Size and Growth Rate of ALN-TTRsc02

      • 3.4.3 Market Size and Growth Rate of CRX-1008

      • 3.4.4 Market Size and Growth Rate of EDE-1307

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Transthyretin Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Transthyretin by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Transthyretin in Familial Amyloid Neuropathies

      • 4.4.2 Market Size and Growth Rate of Transthyretin in Alzheimer's Disease

      • 4.4.3 Market Size and Growth Rate of Transthyretin in Cardomyopathy

      • 4.4.4 Market Size and Growth Rate of Transthyretin in Neuropathy

      • 4.4.5 Market Size and Growth Rate of Transthyretin in Others

    5 Market Analysis by Regions

    • 5.1 USA Transthyretin Production Analysis by Regions

    • 5.2 USA Transthyretin Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Transthyretin Landscape Analysis

    • 6.1 West USA Transthyretin Landscape Analysis by Major Types

    • 6.2 West USA Transthyretin Landscape Analysis by Major End-Users

    7 South USA Transthyretin Landscape Analysis

    • 7.1 South USA Transthyretin Landscape Analysis by Major Types

    • 7.2 South USA Transthyretin Landscape Analysis by Major End-Users

    8 Middle West USA Transthyretin Landscape Analysis

    • 8.1 Middle West USA Transthyretin Landscape Analysis by Major Types

    • 8.2 Middle West USA Transthyretin Landscape Analysis by Major End-Users

    9 Northeast USA Transthyretin Landscape Analysis

    • 9.1 Northeast USA Transthyretin Landscape Analysis by Major Types

    • 9.2 Northeast USA Transthyretin Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Neurimmune Holding AG

        • 10.1.1 Neurimmune Holding AG Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Prothena Corp Plc

        • 10.2.1 Prothena Corp Plc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Pfizer Inc

        • 10.3.1 Pfizer Inc Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Ionis Pharmaceuticals Inc

        • 10.4.1 Ionis Pharmaceuticals Inc Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Regeneron Pharmaceuticals Inc

        • 10.5.1 Regeneron Pharmaceuticals Inc Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Arcturus Therapeutics Inc

        • 10.6.1 Arcturus Therapeutics Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Alnylam Pharmaceuticals Inc

        • 10.7.1 Alnylam Pharmaceuticals Inc Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Transthyretin Market Size and Growth Rate of AG-10 from 2016 to 2027

    • Figure USA Transthyretin Market Size and Growth Rate of ALN-TTRsc02 from 2016 to 2027

    • Figure USA Transthyretin Market Size and Growth Rate of CRX-1008 from 2016 to 2027

    • Figure USA Transthyretin Market Size and Growth Rate of EDE-1307 from 2016 to 2027

    • Figure USA Transthyretin Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Transthyretin Market Size and Growth Rate of Familial Amyloid Neuropathies from 2016 to 2027

    • Figure USA Transthyretin Market Size and Growth Rate of Alzheimer's Disease from 2016 to 2027

    • Figure USA Transthyretin Market Size and Growth Rate of Cardomyopathy from 2016 to 2027

    • Figure USA Transthyretin Market Size and Growth Rate of Neuropathy from 2016 to 2027

    • Figure USA Transthyretin Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Transthyretin Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Transthyretin Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Transthyretin Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Transthyretin Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Transthyretin Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Transthyretin

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Transthyretin by Different Types from 2016 to 2027

    • Table Consumption Share of Transthyretin by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of AG-10

    • Figure Market Size and Growth Rate of ALN-TTRsc02

    • Figure Market Size and Growth Rate of CRX-1008

    • Figure Market Size and Growth Rate of EDE-1307

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Transthyretin by Different End-Users from 2016 to 2027

    • Table Consumption Share of Transthyretin by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Familial Amyloid Neuropathies

    • Figure Market Size and Growth Rate of Alzheimer's Disease

    • Figure Market Size and Growth Rate of Cardomyopathy

    • Figure Market Size and Growth Rate of Neuropathy

    • Figure Market Size and Growth Rate of Others

    • Table USA Transthyretin Production by Regions

    • Table USA Transthyretin Production Share by Regions

    • Figure USA Transthyretin Production Share by Regions in 2016

    • Figure USA Transthyretin Production Share by Regions in 2021

    • Figure USA Transthyretin Production Share by Regions in 2027

    • Table USA Transthyretin Consumption by Regions

    • Table USA Transthyretin Consumption Share by Regions

    • Figure USA Transthyretin Consumption Share by Regions in 2016

    • Figure USA Transthyretin Consumption Share by Regions in 2021

    • Figure USA Transthyretin Consumption Share by Regions in 2027

    • Table West USA Transthyretin Consumption by Types from 2016 to 2027

    • Table West USA Transthyretin Consumption Share by Types from 2016 to 2027

    • Figure West USA Transthyretin Consumption Share by Types in 2016

    • Figure West USA Transthyretin Consumption Share by Types in 2021

    • Figure West USA Transthyretin Consumption Share by Types in 2027

    • Table West USA Transthyretin Consumption by End-Users from 2016 to 2027

    • Table West USA Transthyretin Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Transthyretin Consumption Share by End-Users in 2016

    • Figure West USA Transthyretin Consumption Share by End-Users in 2021

    • Figure West USA Transthyretin Consumption Share by End-Users in 2027

    • Table South USA Transthyretin Consumption by Types from 2016 to 2027

    • Table South USA Transthyretin Consumption Share by Types from 2016 to 2027

    • Figure South USA Transthyretin Consumption Share by Types in 2016

    • Figure South USA Transthyretin Consumption Share by Types in 2021

    • Figure South USA Transthyretin Consumption Share by Types in 2027

    • Table South USA Transthyretin Consumption by End-Users from 2016 to 2027

    • Table South USA Transthyretin Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Transthyretin Consumption Share by End-Users in 2016

    • Figure South USA Transthyretin Consumption Share by End-Users in 2021

    • Figure South USA Transthyretin Consumption Share by End-Users in 2027

    • Table Middle West USA Transthyretin Consumption by Types from 2016 to 2027

    • Table Middle West USA Transthyretin Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Transthyretin Consumption Share by Types in 2016

    • Figure Middle West USA Transthyretin Consumption Share by Types in 2021

    • Figure Middle West USA Transthyretin Consumption Share by Types in 2027

    • Table Middle West USA Transthyretin Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Transthyretin Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Transthyretin Consumption Share by End-Users in 2016

    • Figure Middle West USA Transthyretin Consumption Share by End-Users in 2021

    • Figure Middle West USA Transthyretin Consumption Share by End-Users in 2027

    • Table Northeast USA Transthyretin Consumption by Types from 2016 to 2027

    • Table Northeast USA Transthyretin Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Transthyretin Consumption Share by Types in 2016

    • Figure Northeast USA Transthyretin Consumption Share by Types in 2021

    • Figure Northeast USA Transthyretin Consumption Share by Types in 2027

    • Table Northeast USA Transthyretin Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Transthyretin Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Transthyretin Consumption Share by End-Users in 2016

    • Figure Northeast USA Transthyretin Consumption Share by End-Users in 2021

    • Figure Northeast USA Transthyretin Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Neurimmune Holding AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neurimmune Holding AG

    • Figure Sales and Growth Rate Analysis of Neurimmune Holding AG

    • Figure Revenue and Market Share Analysis of Neurimmune Holding AG

    • Table Product and Service Introduction of Neurimmune Holding AG

    • Table Company Profile and Development Status of Prothena Corp Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prothena Corp Plc

    • Figure Sales and Growth Rate Analysis of Prothena Corp Plc

    • Figure Revenue and Market Share Analysis of Prothena Corp Plc

    • Table Product and Service Introduction of Prothena Corp Plc

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Ionis Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ionis Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Ionis Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Ionis Pharmaceuticals Inc

    • Table Product and Service Introduction of Ionis Pharmaceuticals Inc

    • Table Company Profile and Development Status of Regeneron Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regeneron Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Regeneron Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Regeneron Pharmaceuticals Inc

    • Table Product and Service Introduction of Regeneron Pharmaceuticals Inc

    • Table Company Profile and Development Status of Arcturus Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arcturus Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Arcturus Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Arcturus Therapeutics Inc

    • Table Product and Service Introduction of Arcturus Therapeutics Inc

    • Table Company Profile and Development Status of Alnylam Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals Inc

    • Table Product and Service Introduction of Alnylam Pharmaceuticals Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.